Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Lilly is studying retatrutide in several phase 3 clinical trials to evaluate its potential efficacy and safety across several indications, including obesity and overweight with 1 weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
it occurs with all significant calorie restriction
This is partially a consequence of the fact that many potential protein-encoding genes in the human genome are still uncharacterized
We do not yet have comprehensive human data spanning years of continuous use
Energy, Performance, and Vitality Support Balanced GH signaling may contribute to improved stamina, physical performance, and overall sense of well-being
US$ 26.63
US$ 27.43
US$ 27.77
US$ 23.98
